Technology

Foxit Named One of the Best Software Companies on G2's 2025 Best Software Awards

Foxit Also Recognized for Foxit PDF Editor in Best Collaboration & Productivity Products and Foxit eSign in Best Sales Software Products

03-03 Foxit

Ragnarok Landverse Genesis Closed Beta 2 Begins

SINGAPORE,Feb. 28,2025-- Ragnarok Landverse Genesis Closed Beta Test 2 (CBT2) is scheduled to take place from March 17 to 23,2025. This announcement has ignited excitement among Ragnarok Online fans,g

03-03 Maxion Pte. Ltd.

Coordinated regional strategy pays dividends

BEIJING,Feb. 27,2025-- A news report from China Daily: This year marks the 11th anniversary of theBeijing-Tianjin-Hebei coordinated development,a strategy that has reshaped the area.

02-28

VIVOTEK Enhances Student Safety with AI Security at KA Beveren Sports School in Belgium

TAIPEI,Feb. 27,2025-- Background KA Beverenis a sports school located in Belgium,known for providing sports education and nurturing many student-athletes. Recently KA Beveren underwent a significant u

02-28

STAK Inc. Announces Closing of Initial Public Offering

CHANGZHOU,China,Feb. 28,2025-- STAK Inc. (the "Company") (Nasdaq: STAK),a fast-growing company specializing in the research,development,manufacturing,and sale of oilfield-specialized product

02-28

Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its Industry-leading Integrated Bioinformatics Platform

Metabolon\'s expertise extends beyond metabolomics to include data insights and software solutions for multiomics research

02-28

Mexico Reaches Record 35.1 Million Vehicles in Operation, Reveals Integrate Data Facts (IDF)

ROCHESTER HILLS,Mich.,Feb. 28,2025-- Integrate Data Facts (IDF) today announced the results of its 2024 year-end Vehicles in Operation (VIO) study for Mexico,revealing a record-breaking 35.1 million

02-28

Akeso Announces First ADC Drug Clinical Trial, Marking a New Era for "IO 2.0 + ADC" Strategy

HONG KONG,Feb. 27,2025-- Akeso,Inc. (9926.HK) announced the first patient has been enrolled in the Phase I clinical trial of AK138 D1 for the treatment of advanced malignancies in Australia. AK138D1,a

02-28 Akeso, Inc.

Internet Access: UNESCO and ICANN Join Forces to Improve Linguistic Diversity Online

PARIS and LOS ANGELES,Feb. 27,2025-- UNESCO and the Internet Corporation for Assigned Names and Numbers (ICANN) are announcing a new agreement to enhance linguistic diversity in the digital world. T

02-28 ICANN

Sekisui Specialty Chemicals Achieves ISCC PLUS Certification, Advancing Sustainability in Polymer Production

DALLAS,Feb. 27,2025--Sekisui Specialty Chemicals is proud to announce that it has earned the International Sustainability and Carbon Certification (ISCC PLUS) for a broad suite of its Selvol™ Polyvin

02-28 Sekisui Specialty Chemicals